Sort
21,453 grants matching “tuberculosis”
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
$190,125Kyle H Rohde · University Of Central Florida · R21 · FY2022 · AI
Screening for inhibitors of M. tuberculosis persistence-related lipid metabolism
$190,099Robert B Abramovitch · Michigan State University · R21 · FY2013 · AI
Improving outcomes in HIV-associated opportunistic infections using CNS pharmacokinetics and pharmacodynamics
$190,085Melanie Rae Nicol · University Of Minnesota · R01 · FY2025 · NS
Macrophages and Resistance to Mycobacterium Tuberculosis Infection in Humans
$190,080Jason Simmons · University Of Washington · K08 · FY2022 · AI
The role of antibodies in infant TB prevention
$190,080Lisa M Cranmer · Emory University · K23 · FY2022 · AI
Re-educating T cell-mediated immunity in SIV by modulating metabolic pathways
$190,027Erica Christine Larson · University Of Pittsburgh At Pittsburgh · K01 · FY2023 · OD
The role of antibodies in infant TB prevention
$190,008Lisa M Cranmer · Emory University · K23 · FY2019 · AI
Inhibition of the host cell AIM2 inflammasome by Mycobacterium tuberculosis
$190,000Volker Briken · Univ Of Maryland, College Park · R21 · FY2015 · AI
Adjunct therapeutic potential of a repurposed drug inhibiting Mycobacterium abscessus biofilm formation
$190,000Mary Jackson · Colorado State University · R21 · FY2021 · AI
The Pros and Cons of Trained Immunity Induced by Vaccines for Tuberculosis Prevention
$190,000Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2016 · AI
Alternative functions for gamma delta T cells in the immune response to Mycobacterium
$190,000Jodi L. McGill · University Of Kansas Lawrence · P20 · FY2017 · GM
Basis of Gene Regulation by Purine and Cobalamine Riboswitches
$190,000Robert Todd Batey · University Of Colorado · R01 · FY2015 · GM
Mycobacterium tuberculosis methylglucose lipopolysaccharides
$190,000Mary Jackson · Colorado State University · R21 · FY2019 · AI
Characterization of the ESX-5 secretome and its impact on virulence mechanisms of Mycobacterium tuberculosis
$190,000Volker Briken · Univ Of Maryland, College Park · R21 · FY2018 · AI
Modulation of immunity to tuberculosis through vitamin A-dependent nuclear receptors
$190,000Brendan Podell · Colorado State University · R21 · FY2019 · AI
CRISPRi-based discovery and in vivo validation of drug targets in M. abscessus
$190,000Kyle H Rohde · University Of Central Florida · R21 · FY2022 · AI
EARLY PULMONARY HOST DEFENSE IN M. TUBERCULOSIS INFECTIO
$190,000University Of Washington · R01 · FY2000 · HL
The role of antibodies in infant TB prevention
$189,984Lisa M Cranmer · Emory University · K23 · FY2020 · AI
The role of antibodies in infant TB prevention
$189,968Lisa M Cranmer · Emory University · K23 · FY2021 · AI
The role of antibodies in infant TB prevention
$189,960Lisa M Cranmer · Emory University · K23 · FY2023 · AI
Regulation of Inflammatory Signaling during the Innate Immune Response
$189,956Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2010 · AI
Novel inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR)
$189,956Yongcheng Song · Baylor College Of Medicine · R21 · FY2011 · AI
TUBERCULOSIS PREVENTION, CONTROL/ELIMINATION, LABORATORY, AND HUMAN RESOURCES DEV
$189,938Canyon Hardesty · Wyoming State Department Of Health · U52 · FY2011 · PS
The in vivo effect of vitamin D on Mycobacterium tuberculosis infection
$189,878Padmini Salgame · Rbhs-New Jersey Medical School · R21 · FY2017 · AI
Host and Pathogen Diversity in Mtb and SIV Infection
$189,843Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R21 · FY2016 · AI